Stay updated with our latest news and announcements.
26 nov. 2024
UPyTher and TU/e successfully complete project on hydrogels for immuno-oncology
The collaborative project, funded by the Metropoolregio Eindhoven, focused on the development of hydrogels that treat peritoneal tumours by activating the immune system
UPyTher warmly welcomes Helmuth van Es on its Board of Advisors
Helmuth brings over 30 years of experience in the biotech industry. His addition to the team will boost the growth of UPyTher and advancement of the company's lead product UPT-211 to the clinical stage.
OPZuid funding for collaboration project with SupraPolix
Funding from Europe and the Province of North Brabant for Eindhoven based companies UPyTher and SupraPolix BV to bring a novel and improved therapy to patients with peritoneal cancer, with a total budget of EUR 2.8 million.